Adam David Sachs Sells 943 Shares of Vicarious Surgical Inc (NYSE:RBOT) Stock

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 943 shares of the stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $14.53, for a total transaction of $13,701.79. Following the sale, the chief executive officer now owns 52,699 shares of the company’s stock, valued at $765,716.47. This trade represents a 1.76 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Adam David Sachs also recently made the following trade(s):

• On Monday, December 23rd, Adam David Sachs sold 139 shares of Vicarious Surgical stock. The stock was sold at an average price of $12.27, for a total transaction of $1,705.53.
• On Tuesday, December 3rd, Adam David Sachs sold 463 shares of Vicarious Surgical stock. The stock was sold at an average price of $13.50, for a total transaction of $6,250.50.

Vicarious Surgical Trading Down 1.6 %

RBOT opened at $14.38 on Friday. The stock has a market capitalization of $84.99 million, a PE ratio of -1.40 and a beta of 1.32. Vicarious Surgical Inc has a 1-year low of $4.27 and a 1-year high of $19.00. The firm has a 50-day moving average price of $13.65 and a two-hundred day moving average price of $10.11.

Institutional Investors Weigh In On Vicarious Surgical

Institutional investors have recently modified their holdings of the business. Renaissance Technologies LLC grew its position in shares of Vicarious Surgical by 11.6% during the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after buying an additional 1,200 shares during the period. DnB Asset Management AS grew its position in shares of Vicarious Surgical by 21.1% during the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after buying an additional 3,692 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Vicarious Surgical by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after buying an additional 2,336 shares during the period. Institutional investors and hedge funds own 47.27% of the company’s stock.

Analyst Ratings Changes

Separately, Piper Sandler dropped their target price on shares of Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating for the company in a research report on Wednesday, November 13th.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.